Get started

Stockpicks

$XELAExela Technologies, Inc. provides transaction processing solutions, enterprise information management, document management, and digital business process services worldwide. The company operates through three segments: Information & Transaction Processing Solutions (ITPS), Healthcare Solutions (HS), and Legal & Loss Prevention Services (LLPS). The ITPS segment provides lending solutions for mortgages and auto loans; banking solutions for clearing, anti-money laundering, sanctions, and interbank cross-border settlement; property and casualty insurance solutions for origination, enrollments, claims processing, and benefits administration communications; and public sector solutions for income tax processing, benefits administration, and records management. It also offers solutions for payment processing and reconciliation, integrated receivable and payables management, document logistics and location services, records management, and electronic storage of data/documents; and software, hardware, professional services, and maintenance related to information and transaction processing automation. The HS segment provides revenue cycle solutions, integrated accounts payable and accounts receivable, and information management for healthcare payer and provider markets. The LLPS segment processes legal claims for class action and mass action settlement administrations, involving project management support, notification, and outreach to claimants; and collects, analyzes, and distributes settlement funds. It also offers data and analytical services in the area of litigation consulting, economic and statistical analysis, expert witness services, and revenue recovery services for delinquent accounts receivable. The company is headquartered in Irving, Texas.
XLong
by BADQOMOCAWGOWLD
$TGGI Sky Highhhh $TGGI is looking good - a Chinese guy who already established his wine company in China and listed on Chinese stock exchange wants to now list his stock / company on NASDAQ. So he bought TGGI recently. $TGGI reverse merger play owned my capital intersection LLC (who also owns FTWS and BLUU) Currently Chinese nanotech wine company wants to use the shell and up list to Nasdaq $TGGI if it hits a dollar without restructure of SS...200 to 34k #davidlazar #moody&denuzio #capital intersection (fm @Tree_Roots) $TGGI is looking good - a Chinese guy who already established his wine company in China and listed on Chinese stock exchange wants to now list his stock / company on NASDAQ. So he bought TGGI recently. (fm @Stockslol)
OTC:TGGILong
by BADQOMOCAWGOWLD
2
$JFIN appear to be rising on news or speculation regarding NFTsShares of $JFIN appear to be rising on news or speculation regarding NFTs. For those of you that don't know, NFTs are digital files such as art, video, audio, and other files stored on blockchain, which is the digital ledger technology that powers cryptocurrencies like Bitcoin. Some NFTs have already sold for millions of dollars. Jiayin appear to be linked to speculation that the company may eventually jump into the NFT space. Jiayin is an online individual loan marketplace that seeks to reach underserved customers in China. However, recent buzz on Twitter has people saying the company could potentially get into the NFT space, although there is no real news pointing to that right now. The hype and potential around NFT is certainly at an all-time high and eerily reminiscent of when cryptocurrencies, which are also powered by blockchain, first gained mass popularity several years ago. I would advise caution on anything related to NFTs. While they certainly have taken off in recent months, we are still in very days where the market for these assets will likely remain extremely volatile for quite some time. www.fool.com
NASDAQ:JFIN
by AlenCiken
CEMI Technical Analysis 🧙Chembio Diagnostics Inc is a company that develops, manufactures, and commercializes point-of-care diagnostic tests that detect infectious diseases. The products of the company include rapid tests for the detection of HIV 1/2 antibodies and a multiplex rapid test for the detection of HIV and syphilis antibodies. The company offered rapid medical tests that are offered in Africa, Asia, Europe, and the Middle East, Latin America and the United States, of which key revenue is derived from Latin America. If you want more trading ideas like this one ,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
CLong
by unfair_advantage
$TKAT surged yesterday due to hype in NFT art?The Hong Kong-based online art trading platform rose prompted by increased attention from social media amid frenzy surrounding non-fungible tokens. NFTs are akin to a digital certificate of ownership. Takung provides collectors a way to jointly own Asian and other fine arts including paintings, calligraphies, jewelry, and precious gems, according to its website. The hype in NFT art ranging from sneakers to memes have been in the focus of late and a piece from Beeple — “The First 5000 Days” — commanded price tags of millions of dollars. Tesla Inc TSLA CEO Elon Musk also jumped on the bandwagon and put an NFT song — on NFTs — for sale, which the artist Beeple offered to purchase for $69 million, but later changed his mind. www.benzinga.com
T
by AlenCiken
$SVRA Announces Closing of $130 Million Public OfferingSavara Announces Pricing of Public Offering of Common Stock $SVRA today announced the pricing of an underwritten public offering of 45,785,828 shares of its common stock at a price to the public of $1.45 per share. As a component of the offering, in lieu of shares of common stock, Savara offered to certain existing investors pre-funded warrants to purchase an aggregate of 32,175,172 shares of common stock at a purchase price of $1.449 per warrant, which represents the per share public offering price for the common stock less the $0.001 per share exercise price for each pre-funded warrant. finance.yahoo.com Savara Announces Closing of $130 Million Public Offering Following Full Exercise of Underwriters’ Option finance.yahoo.com
NASDAQ:SVRA
by AlenCiken
NIKE Stock 16/03/21 Analysis 4H ChartNYSE:NKE - Trend Analysis - 📑Value: 0/20 📈Growth: 18/20 💰Profitability: 20/20 🚀Momentum: 8/20 💸Earnings: 16/20 🖇️Total Score: 62/100 Analysis: Low: $41 Average: $72.83 High: $105 Current: $72.96 Data: Volume 3.74M Average Volume (3 months) 5.71M Previous Close $144.94 Open $145.88 Shares Outstanding 1.27B Technicals: (Simple Moving Average) 10D SMA $137.13 (+5.55%) 50D SMA $139.63 (+3.67) 200D SMA $122.39 (+18.27%) Market Cap $221.42B Total Debt $12.80B Cash $11.81B Enterprise Value $222.41B Dividend Yield 0.76% Annual Payout $1.10 Payout Ratio 36.88% Years of Growth 19 Years Latest Announced Dividend $0.28 Ex-Dividend Date 26/02/2021 Payout Date 01/04/2021 Revenue $38.25B Gross Profit $16.44B Net Income $2.83B EPS Diluted $1.77 Free Cash Flow / Share $2.32
NYSE:NKELong
by investor_kings
$QS PT 120 and higherQuantumScape, a developer of what are known as solid-state batteries, has entered into a definitive agreement to merge with blank check company Kensington Capital Acquisition Corp. EV battery manufacturer backed by Bill Gates and Volkswagen. Implied Value of combined companies is $3.3B QuantumScape Corporation engages in the development and commercialization of solid-state lithium-metal batteries for electric vehicles. The company was founded in 2010 and is headquartered in San Jose, California
NYSE:QSLong
by BADQOMOCAWGOWLD
1
DKNG Stock 12/03/21 Analysis 4H Chart(DRAFTKINGS: DKNG ) - Trend Analysis - 📑Value: 0/20 📈Growth: 14/20 💰Profitability: 14/20 🚀Momentum: 20/20 💸Earnings: 14/20 🖇️Total Score: 62/100 Analysis: Low: $41 Average: $72.83 High: $105 Current: $72.96 Income Statement: Revenue: $614.53M Gross Profit: $267.94M EBITDA: ----- Net Income: ----- EPS Diluted: -$2.76 Cash Flow Statement: Cash from Operations: -$337.88M Cash from Investing: -$227.34M Levered Free Cash Flow: -$49.38M Unlevered Free Cash Flow: -$48.72M Free Cash Flow: -$1.26 Balance Sheet: Total Cash: $1.82B Total Debt: $81.61M Total Debt to Equity: 3.03% Current Ratio: 3.96 Quick Ratio: 3.96
NASDAQ:DKNGLong
by investor_kings
$SEEL PT 90 and higherSeelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing of novel technologies and therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in patients with major depressive disorder and post-traumatic stress disorder; SLS-005, a protein stabilizer for the treatment of Sanfilippo syndrome; and SLS-006, a partial dopamine agonist for the treatment of patients with Parkinson's disease (PD). Its preclinical programs include SLS-007, an anti-alpha-synuclein peptidic inhibitor to treat patients with PD; SLS-008, an orally available antagonist for chemoattractant receptor-homologous molecule for the treatment of chronic inflammation in asthma and pediatric orphan indications; SLS-004 for the treatment of PD; SLS-010, an oral histamine H3A receptor antagonist for narcolepsy and related disorders; and SLS-012, an injectable therapy for post-operative pain management. Seelos Therapeutics, Inc. was founded in 2016 and is headquartered in New York, New York.
SLong
by BADQOMOCAWGOWLD